                         SEQUENCE LISTING

<110>  University of Kentucky Research Foundation
       Daunert, Sylvia
       Bachas, Leonidas
       Haley, Boyd
       Joel, Smita
 
<120>  SEMI-SYNTHETIC ANTIBODIES AS RECOGNITION ELEMENTS

<130>  13177N/1498US

<150>  US 60/954,266
<151>  2007-08-06

<160>  44    

<170>  PatentIn version 3.5

<210>  1
<211>  57
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Anti-CTS Light Chain Antibody Fragment

<400>  1

Val Ile Thr Gln Ser Pro Ser Ser Leu Ala Val Ser Ala Gly Glu Arg 
1               5                   10                  15      


Val Thr Met Thr Cys Arg Ser Ser Gln Ser Leu Phe Asn Ser Arg Ile 
            20                  25                  30          


Arg Lys Asn Tyr Leu Ala Trp Tyr Gln His Lys Pro Gly Gln Ser Pro 
        35                  40                  45              


Lys Leu Leu Ile Tyr Trp Ala Ser Thr 
    50                  55          


<210>  2
<211>  56
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Anti-1MRC Light Chain Antibody Fragment

<400>  2

Val Met Thr Gln Thr Pro Leu Ser Leu Pro Val Ser Leu Gly Asp Gln 
1               5                   10                  15      


Ala Ser Ile Ser Cys Arg Ser Ser Gln Ser Leu Val His Ser Asn Gly 
            20                  25                  30          


Asn Thr Tyr Leu His Trp Tyr Leu Gln Lys Pro Gly Gln Ser Pro Lys 
        35                  40                  45              


Leu Leu Ile Tyr Lys Val Ser Asn 
    50                  55      


<210>  3
<211>  57
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Anti-1A3R Light Chain Antibody Fragment

<400>  3

Val Met Thr Gln Ser Pro Ser Ser Leu Thr Val Thr Thr Gly Glu Lys 
1               5                   10                  15      


Val Thr Met Thr Cys Lys Ser Ser Gln Ser Leu Leu Asn Ser Arg Thr 
            20                  25                  30          


Gln Lys Asn Tyr Leu Thr Trp Tyr Gln Gln Lys Pro Gly Gln Ser Pro 
        35                  40                  45              


Lys Leu Leu Ile Tyr Trp Ala Ser Thr 
    50                  55          


<210>  4
<211>  57
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Anti-1A5F Light Chain Antibody Fragment

<400>  4

Val Met Thr Gln Ser Pro Ser Ser Leu Thr Val Thr Thr Gly Glu Lys 
1               5                   10                  15      


Val Thr Met Thr Cys Lys Ser Ser Gln Ser Leu Leu Asn Ser Gly Ala 
            20                  25                  30          


Gln Lys Asn Tyr Leu Thr Trp Tyr Gln Gln Lys Pro Gly Gln Ser Pro 
        35                  40                  45              


Lys Leu Leu Ile Tyr Trp Ala Ser Thr 
    50                  55          


<210>  5
<211>  56
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Anti-1KEG Light Chain Antibody Fragment

<400>  5

Leu Met Thr Gln Thr Pro Leu Ser Leu Pro Val Ser Leu Gly Asp Gln 
1               5                   10                  15      


Ala Ser Ile Ser Cys Arg Ser Ser Gln Ser Ile Val His Ser Asn Gly 
            20                  25                  30          


Asn Thr Tyr Leu Glu Trp Tyr Leu Gln Lys Pro Gly Gln Ser Pro Lys 
        35                  40                  45              


Leu Leu Ile Tyr Lys Val Ser Asn 
    50                  55      


<210>  6
<211>  56
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Anti-1M71 Light Chain Antibody Fragment

<400>  6

Val Leu Thr Gln Thr Pro Leu Ser Leu Pro Val Arg Leu Gly Asp Gln 
1               5                   10                  15      


Ala Ser Ile Ser Cys Arg Ser Ser Gln Ser Leu Leu His Ser Asp Gly 
            20                  25                  30          


Asn Thr Tyr Leu His Trp Tyr Leu Gln Lys Pro Gly Gln Ser Pro Lys 
        35                  40                  45              


Leu Leu Ile Tyr Lys Val Ser Asn 
    50                  55      


<210>  7
<211>  56
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Anti-1CL7 Light Chain Antibody Fragment

<400>  7

Leu Met Thr Gln Thr Pro Leu Tyr Leu Pro Val Ser Leu Gly Asp Gln 
1               5                   10                  15      


Ala Ser Ile Ser Cys Arg Ser Ser Gln Thr Ile Val His Asn Asn Gly 
            20                  25                  30          


Asn Thr Tyr Leu Glu Trp Tyr Leu Gln Lys Pro Gly Gln Ser Pro Gln 
        35                  40                  45              


Leu Leu Ile Tyr Lys Val Ser Asn 
    50                  55      


<210>  8
<211>  56
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Anti-1FPT Light Chain Antibody Fragment

<400>  8

Val Met Thr Gln Thr Pro Leu Ser Leu Pro Val Ser Leu Gly Asp Gln 
1               5                   10                  15      


Ala Ser Ile Ser Cys Ser Ser Ser Gln Ser Leu Val His Ser Asn Gly 
            20                  25                  30          


Lys Thr Tyr Leu His Trp Tyr Leu Gln Lys Pro Gly Gln Ser Pro Lys 
        35                  40                  45              


Leu Leu Ile Tyr Lys Val Ser Asn 
    50                  55      


<210>  9
<211>  56
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Anti-1CR9 Light Chain Antibody Fragment

<400>  9

Val Met Thr Gln Thr Pro Leu Ser Leu Ser Val Thr Ile Gly Gln Pro 
1               5                   10                  15      


Ala Ser Ile Ser Cys Lys Ser Ser Gln Ser Leu Leu Asp Ser Asp Gly 
            20                  25                  30          


Lys Thr Tyr Leu Ile Trp Val Phe Gln Arg Pro Gly Gln Ser Pro Lys 
        35                  40                  45              


Arg Leu Ile Phe Leu Val Ser Lys 
    50                  55      


<210>  10
<211>  56
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Anti-1S51 Light Chain Antibody Fragment

<400>  10

Gln Met Thr Gln Thr Pro Leu Thr Leu Ser Val Thr Ile Gly Gln Pro 
1               5                   10                  15      


Ala Ser Ile Ser Cys Glu Ser Ser Gln Ser Leu Leu Tyr Ser Asn Gly 
            20                  25                  30          


Lys Thr Tyr Leu Asn Trp Leu Leu Gln Arg Pro Gly Gln Ser Pro Lys 
        35                  40                  45              


Arg Leu Ile Tyr Leu Val Ser Lys 
    50                  55      


<210>  11
<211>  56
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Anti-1RUK Light Chain Antibody Fragment

<400>  11

Val Met Thr Gln Ser Pro Lys Thr Ile Ser Val Thr Ile Gly Gln Pro 
1               5                   10                  15      


Ala Ser Ile Ser Cys Lys Ser Ser Gln Arg Leu Leu Asn Ser Asn Gly 
            20                  25                  30          


Lys Thr Phe Leu Asn Trp Leu Leu Gln Arg Pro Gly Gln Ser Pro Lys 
        35                  40                  45              


Arg Leu Ile Tyr Leu Gly Thr Lys 
    50                  55      


<210>  12
<211>  56
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Anti-1KEL Light Chain Antibody Fragment

<400>  12

Leu Met Thr Gln Thr Pro Leu Ser Leu Pro Val Ser Leu Gly Asp Gln 
1               5                   10                  15      


Ala Ser Ile Ser Cys Arg Phe Ser Gln Ser Ile Val His Ser Asn Gly 
            20                  25                  30          


Asn Thr Tyr Leu Glu Trp Tyr Leu Gln Lys Ser Gly Gln Ser Pro Lys 
        35                  40                  45              


Leu Leu Ile Tyr Lys Val Ser Asn 
    50                  55      


<210>  13
<211>  56
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Anti-1MJ8 Light Chain Antibody Fragment

<400>  13

Val Met Thr Gln Ala Ala Pro Ser Val Pro Val Thr Pro Gly Glu Ser 
1               5                   10                  15      


Val Ser Ile Ser Cys Arg Ser Ser Lys Ser Leu Leu His Ser Asn Gly 
            20                  25                  30          


Asn Thr Tyr Leu Tyr Trp Phe Leu Gln Arg Pro Gly Gln Ser Pro Gln 
        35                  40                  45              


Leu Leu Ile Tyr Arg Met Ser Asn 
    50                  55      


<210>  14
<211>  56
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Anti-2AJX Light Chain Antibody Fragment

<400>  14

Val Ile Thr Gln Asp Glu Leu Ser Asn Pro Val Thr Ser Gly Glu Ser 
1               5                   10                  15      


Val Ser Ile Ser Cys Arg Ser Ser Arg Ser Leu Leu Tyr Lys Asp Gly 
            20                  25                  30          


Arg Thr Tyr Leu Asn Trp Phe Leu Gln Arg Pro Gly Gln Ser Pro Gln 
        35                  40                  45              


Leu Leu Ile Tyr Leu Met Ser Thr 
    50                  55      


<210>  15
<211>  52
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Anti-1AIF Light Chain Antibody Fragment

<400>  15

Gln Leu Thr Gln Ser Pro Ala Phe Met Ala Ala Ser Pro Gly Glu Lys 
1               5                   10                  15      


Val Thr Ile Thr Cys Ser Val Ser Ser Ser Ile Ser Ser Ser Asn Leu 
            20                  25                  30          


His Trp Tyr Gln Gln Lys Ser Glu Thr Ser Pro Lys Pro Trp Ile Tyr 
        35                  40                  45              


Gly Thr Ser Asn 
    50          


<210>  16
<211>  55
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Anti-2F58 Light Chain Antibody Fragment

<400>  16

Val Leu Thr Gln Ser Pro Ala Ser Leu Ala Val Ser Leu Gly Gln Arg 
1               5                   10                  15      


Ala Thr Ile Ser Cys Lys Ala Ser Gln Gly Val Asp Phe Asp Gly Ala 
            20                  25                  30          


Ser Phe Met Asn Trp Tyr Gln Gln Lys Pro Gly Gln Pro Pro Lys Leu 
        35                  40                  45              


Leu Ile Phe Ala Ala Ser Thr 
    50                  55  


<210>  17
<211>  51
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Anti-1EMT Light Chain Antibody Fragment

<400>  17

Gln Met Thr Gln Thr Thr Ser Ser Leu Ser Ala Ser Leu Gly Asp Arg 
1               5                   10                  15      


Val Thr Phe Ser Cys Ser Ala Ser Gln Asp Ile Ser Asn Tyr Leu Asn 
            20                  25                  30          


Trp Tyr Gln Gln Lys Pro Asp Gly Thr Ile Lys Leu Leu Ile Tyr Tyr 
        35                  40                  45              


Thr Ser Ser 
    50      


<210>  18
<211>  51
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Anti-2A6I Light Chain Antibody Fragment

<400>  18

Gln Met Thr Gln Thr Thr Ser Ser Leu Ser Ala Ser Leu Gly Asp Arg 
1               5                   10                  15      


Val Thr Ile Ser Cys Arg Ala Ser Gln Asp Ile Ser Asn Tyr Leu Asn 
            20                  25                  30          


Trp Tyr Gln Gln Lys Pro Asp Gly Thr Val Lys Leu Leu Ile Tyr Tyr 
        35                  40                  45              


Thr Ser Arg 
    50      


<210>  19
<211>  51
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Anti-1FGN Light Chain Antibody Fragment

<400>  19

Lys Met Thr Gln Ser Pro Ser Ser Met Tyr Ala Ser Leu Gly Glu Arg 
1               5                   10                  15      


Val Thr Ile Thr Cys Lys Ala Ser Gln Asp Ile Arg Lys Tyr Leu Asn 
            20                  25                  30          


Trp Tyr Gln Gln Lys Pro Trp Lys Ser Pro Lys Thr Leu Ile Tyr Tyr 
        35                  40                  45              


Ala Thr Ser 
    50      


<210>  20
<211>  51
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Anti-1QBM Light Chain Antibody Fragment

<400>  20

Gln Met Thr Gln Ser Pro Ala Ser Leu Ser Ala Ser Val Gly Glu Thr 
1               5                   10                  15      


Val Thr Ile Thr Cys Arg Ala Ser Gly Asn Ile His Asn Tyr Leu Ala 
            20                  25                  30          


Trp Tyr Gln Gln Lys Gln Gly Lys Ser Pro Gln Leu Leu Val Tyr Asn 
        35                  40                  45              


Ala Lys Thr 
    50      


<210>  21
<211>  51
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Anti-1R3I Light Chain Antibody Fragment

<400>  21

Leu Leu Thr Gln Ser Pro Ala Ile Leu Ser Val Ser Pro Gly Glu Arg 
1               5                   10                  15      


Val Ser Phe Ser Cys Arg Ala Ser Gln Ser Ile Gly Thr Asp Ile His 
            20                  25                  30          


Trp Tyr Gln Gln Arg Thr Asn Gly Ser Pro Arg Leu Leu Ile Lys Tyr 
        35                  40                  45              


Ala Ser Glu 
    50      


<210>  22
<211>  51
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Anti-1BEY Light Chain Antibody Fragment

<400>  22

Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly Asp Arg 
1               5                   10                  15      


Val Thr Ile Thr Cys Lys Ala Ser Gln Asn Ile Asp Lys Tyr Leu Asn 
            20                  25                  30          


Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile Tyr Asn 
        35                  40                  45              


Thr Asn Asn 
    50      


<210>  23
<211>  51
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Anti-CTS Heavy Chain Antibody Fragment

<400>  23

Gly Ser Leu Arg Ser Glu Asp Thr Ala Ile Tyr Phe Cys Ala Arg Trp 
1               5                   10                  15      


Ala Ala Tyr Lys His Tyr Phe Asp Tyr Trp Gly Gln Gly Thr Ala Leu 
            20                  25                  30          


Thr Val Ser Ser Ala Lys Thr Thr Pro Pro Ser Val Tyr Pro Leu Ala 
        35                  40                  45              


Pro Gly Cys 
    50      


<210>  24
<211>  48
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Anti-1MRC Heavy Chain Antibody Fragment

<400>  24

Ser Ser Leu Thr Ser Glu Asp Ser Ala Val Tyr Tyr Cys Ala Asn Leu 
1               5                   10                  15      


Arg Gly Tyr Phe Asp Tyr Trp Gly Gln Gly Thr Thr Leu Thr Val Ser 
            20                  25                  30          


Ser Ala Lys Thr Thr Pro Pro Ser Val Tyr Pro Leu Ala Pro Gly Cys 
        35                  40                  45              


<210>  25
<211>  50
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Anti-1A3R Heavy Chain Antibody Fragment

<400>  25

Ser Ser Leu Thr Ser Glu Asp Thr Ala Val Tyr Tyr Cys Asp Gly Tyr 
1               5                   10                  15      


Tyr Ser Tyr Tyr Asp Met Asp Tyr Trp Gly Pro Gly Thr Ser Val Thr 
            20                  25                  30          


Val Ser Ser Ala Lys Thr Thr Ala Pro Ser Val Tyr Pro Leu Ala Pro 
        35                  40                  45              


Val Cys 
    50  


<210>  26
<211>  46
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Anti-1CR9 Heavy Chain Antibody Fragment

<400>  26

Ser Ser Leu Thr Ser Glu Asp Thr Ala Val Tyr Tyr Cys Asn Ala Asp 
1               5                   10                  15      


Leu His Asp Tyr Trp Gly Gln Gly Thr Thr Leu Thr Val Ser Ser Ala 
            20                  25                  30          


Lys Thr Thr Ala Pro Ser Val Tyr Pro Leu Ala Pro Val Cys 
        35                  40                  45      


<210>  27
<211>  51
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Anti-1AIF Heavy Chain Antibody Fragment

<400>  27

Asn Ser Leu Arg Ala Glu Asp Thr Gly Ile Tyr Tyr Cys Val Leu Arg 
1               5                   10                  15      


Pro Leu Phe Tyr Tyr Ala Val Asp Tyr Trp Gly Gln Gly Thr Ser Val 
            20                  25                  30          


Thr Val Ser Ser Ala Lys Thr Thr Pro Pro Ser Val Tyr Pro Leu Ala 
        35                  40                  45              


Pro Gly Ser 
    50      


<210>  28
<211>  50
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Anti-1M71Heavy Chain Antibody Fragment

<400>  28

Asn Asn Leu Arg Ala Glu Asp Thr Gly Ile Tyr Tyr Cys Thr Arg Gly 
1               5                   10                  15      


Gly Ala Val Gly Ala Met Asp Tyr Trp Gly Gln Gly Thr Ser Val Thr 
            20                  25                  30          


Val Ser Ser Ala Thr Thr Thr Ala Pro Ser Val Tyr Pro Leu Val Pro 
        35                  40                  45              


Gly Cys 
    50  


<210>  29
<211>  51
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Anti-1BEY Heavy Chain Antibody Fragment

<400>  29

Ser Ser Val Thr Ala Ala Asp Thr Ala Val Tyr Tyr Cys Ala Arg Glu 
1               5                   10                  15      


Gly His Thr Ala Ala Pro Phe Asp Tyr Trp Gly Gln Gly Ser Leu Val 
            20                  25                  30          


Thr Val Ser Ser Ala Ser Thr Lys Gly Pro Ser Val Phe Pro Leu Ala 
        35                  40                  45              


Pro Ser Ser 
    50      


<210>  30
<211>  49
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Anti-1KEL Heavy Chain Antibody Fragment

<400>  30

Asn Thr Leu Arg Ala Glu Asp Ser Ala Thr Tyr Tyr Cys Ala Arg Trp 
1               5                   10                  15      


Gly Ser Tyr Ala Met Asp Tyr Trp Gly Gln Gly Thr Ser Val Thr Val 
            20                  25                  30          


Ser Ser Ala Lys Thr Thr Pro Pro Ser Val Tyr Pro Leu Ala Pro Gly 
        35                  40                  45              


Ser 
    


<210>  31
<211>  51
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Anti-1RUK Heavy Chain Antibody Fragment

<400>  31

Asn Ser Val Thr Thr Glu Asp Thr Ala Thr Tyr Tyr Cys Ala Gly Leu 
1               5                   10                  15      


Leu Trp Tyr Asp Gly Gly Ala Gly Ser Trp Gly Gln Gly Thr Leu Val 
            20                  25                  30          


Thr Val Ser Ala Ala Lys Thr Thr Ala Pro Ser Val Tyr Pro Leu Ala 
        35                  40                  45              


Pro Val Cys 
    50      


<210>  32
<211>  50
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Anti-1S5I Heavy Chain Antibody Fragment

<400>  32

Asn Ser Val Thr Thr Glu Asp Thr Ala Thr Tyr Tyr Cys Ala Ser Tyr 
1               5                   10                  15      


Asp Asp Tyr Thr Trp Phe Thr Tyr Trp Gly Gln Gly Thr Leu Val Thr 
            20                  25                  30          


Val Ser Ala Ala Lys Thr Thr Pro Pro Ser Val Tyr Pro Leu Ala Pro 
        35                  40                  45              


Gly Ser 
    50  


<210>  33
<211>  51
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Anti-2AJX Heavy Chain Antibody Fragment

<400>  33

Asn Ser Val Thr Thr Glu Asp Thr Ala Thr Tyr Tyr Cys Ala Arg Tyr 
1               5                   10                  15      


Asp Tyr Tyr Gly Asn Thr Gly Asp Tyr Trp Gly Gln Gly Thr Ser Val 
            20                  25                  30          


Thr Val Ser Ser Ala Lys Thr Thr Pro Pro Ser Val Tyr Pro Leu Ala 
        35                  40                  45              


Pro Gly Thr 
    50      


<210>  34
<211>  58
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Anti-2F58 Heavy Chain Antibody Fragment

<400>  34

Asn Ser Val Thr Thr Glu Asp Thr Ala Thr Tyr Tyr Cys Ala Arg Glu 
1               5                   10                  15      


Glu Ala Met Pro Tyr Gly Asn Gln Ala Tyr Tyr Tyr Ala Met Asp Cys 
            20                  25                  30          


Trp Gly Gln Gly Thr Thr Val Thr Val Ser Ser Ala Lys Thr Thr Pro 
        35                  40                  45              


Pro Ser Val Tyr Pro Leu Ala Pro Gly Ser 
    50                  55              


<210>  35
<211>  52
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Anti-1A5F Heavy Chain Antibody Fragment

<400>  35

Ser Ser Leu Thr Ser Glu Asp Thr Ala Val Tyr Tyr Cys Ala Arg Val 
1               5                   10                  15      


Gly Leu Ser Tyr Trp Tyr Ala Met Asp Tyr Trp Gly Gln Gly Thr Ser 
            20                  25                  30          


Val Thr Val Ser Ser Ala Lys Thr Thr Pro Pro Ser Val Tyr Pro Leu 
        35                  40                  45              


Ala Pro Gly Ser 
    50          


<210>  36
<211>  49
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Anti-1QBM Heavy Chain Antibody Fragment

<400>  36

Ser Ser Leu Thr Ser Glu Asp Thr Ala Val Tyr Tyr Cys Ala Gly Tyr 
1               5                   10                  15      


Asp Tyr Gly Asn Phe Asp Tyr Trp Gly Gln Gly Thr Thr Leu Thr Val 
            20                  25                  30          


Ser Ser Ala Glu Thr Thr Pro Pro Ser Val Tyr Pro Leu Ala Pro Gly 
        35                  40                  45              


Thr 
    


<210>  37
<211>  45
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Anti-1EMT Heavy Chain Antibody Fragment

<400>  37

Ser Ser Leu Thr Ser Val Asp Ser Ala Val Tyr Phe Cys Ala Thr Ser 
1               5                   10                  15      


Ser Ala Tyr Trp Gly Gln Gly Thr Leu Leu Thr Val Ser Ala Ala Lys 
            20                  25                  30          


Thr Thr Pro Pro Ser Val Tyr Pro Leu Ala Pro Gly Ser 
        35                  40                  45  


<210>  38
<211>  49
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Anti-1FGN Heavy Chain Antibody Fragment

<400>  38

Ser Ser Leu Thr Ser Glu Asp Thr Ala Val Tyr Tyr Cys Ala Arg Asp 
1               5                   10                  15      


Asn Ser Tyr Tyr Phe Asp Tyr Trp Gly Gln Gly Thr Thr Leu Thr Val 
            20                  25                  30          


Ser Ser Ala Lys Thr Thr Pro Pro Ser Val Tyr Pro Leu Ala Pro Gly 
        35                  40                  45              


Ser 
    


<210>  39
<211>  50
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Anti-1R3I Heavy Chain Antibody Fragment

<400>  39

Ser Ser Leu Thr Ser Glu Asp Ser Ala Val Tyr Tyr Cys Ala Arg Glu 
1               5                   10                  15      


Arg Gly Asp Gly Tyr Phe Ala Val Trp Gly Ala Gly Thr Thr Val Thr 
            20                  25                  30          


Val Ser Ser Ala Lys Thr Thr Pro Pro Ser Val Tyr Pro Leu Ala Pro 
        35                  40                  45              


Gly Ser 
    50  


<210>  40
<211>  52
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Anti-1FPT Heavy Chain Antibody Fragment

<400>  40

Ser Ser Leu Thr Ser Asp Asp Ser Ala Val Tyr Phe Cys Ala Arg Asp 
1               5                   10                  15      


Phe Tyr Asp Tyr Asp Val Gly Phe Asp Tyr Trp Gly Gln Gly Thr Thr 
            20                  25                  30          


Leu Thr Val Ser Ser Ala Lys Thr Thr Ala Pro Ser Val Tyr Pro Leu 
        35                  40                  45              


Ala Pro Val Cys 
    50          


<210>  41
<211>  51
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Anti-1MJ8 Heavy Chain Antibody Fragment

<400>  41

Ser Ser Leu Thr Ser Asp Asp Ser Ala Val Tyr Tyr Cys Ala Arg Lys 
1               5                   10                  15      


His Tyr Phe Tyr Asp Gly Val Val Tyr Trp Gly Gln Gly Thr Leu Val 
            20                  25                  30          


Thr Val Ser Ala Ala Lys Thr Thr Ala Pro Ser Val Tyr Pro Leu Ala 
        35                  40                  45              


Pro Val Cys 
    50      


<210>  42
<211>  52
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Anti-1KEG Heavy Chain Antibody Fragment

<400>  42

Ser Ser Leu Thr Asn Glu Asp Ser Ala Val Tyr Tyr Cys Thr Arg Arg 
1               5                   10                  15      


Ser Gly Tyr Lys Tyr Tyr Ala Leu Asp Tyr Trp Gly Gln Gly Thr Ser 
            20                  25                  30          


Val Thr Val Ser Ser Ala Lys Thr Thr Ala Pro Ser Val Tyr Pro Leu 
        35                  40                  45              


Ala Pro Val Cys 
    50          


<210>  43
<211>  53
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Anti-2A6I Heavy Chain Antibody Fragment

<400>  43

Arg Ser Leu Thr Ser Glu Asp Ser Ala Val Tyr Phe Cys Ala Arg Ser 
1               5                   10                  15      


Val Tyr Tyr Gly Gly Ser Tyr Tyr Phe Asp Tyr Trp Gly Gln Gly Thr 
            20                  25                  30          


Thr Leu Thr Val Ser Ser Ala Lys Thr Thr Pro Pro Ser Val Tyr Pro 
        35                  40                  45              


Leu Ala Pro Gly Ser 
    50              


<210>  44
<211>  52
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Anti-1CL7 Heavy Chain Antibody Fragment

<400>  44

Asn Asn Leu Lys Asn Glu Asp Thr Ala Thr Tyr Phe Cys Val Arg Asp 
1               5                   10                  15      


Arg His Asp Tyr Gly Glu Ile Phe Thr Tyr Trp Gly Gln Gly Thr Thr 
            20                  25                  30          


Val Thr Val Ser Ser Ala Lys Thr Thr Pro Pro Ser Val Tyr Pro Leu 
        35                  40                  45              


Ala Pro Gly Ser 
    50          


